Page 9 - Relay Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relay therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relay Therapeutic Today - Breaking & Trending Today

Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event

Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Dan Budwick , Sanjiv Patel , Caroline Glen , Exchange Commission , Relay Therapeutics Inc , Drug Administration , Wall Street , Relay Therapeutics , Relay Therapeutic , Clinical Data , Cancer Portfolio , Private Securities Litigation Reform Act , Annual Report , Quarterly Report ,

Zacks: Analysts Anticipate Relay Therapeutics, Inc. (NASDAQ:RLAY) to Post -$0.63 EPS

Equities analysts predict that Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) will report ($0.63) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Relay Therapeutics’ earnings, with the lowest EPS estimate coming in at ($0.64) and the highest estimate coming in at ($0.63). Relay Therapeutics reported […] ....

New York , United States , Donalda Bergstrom , Dekabank Deutsche Girozentrale , York State Common Retirement Fund , Relay Therapeutics Inc , Zacks Investment Research , Goldman Sachs Group , Great West Life Assurance Co , Royal Bank , Relay Therapeutics , Get Rating , Zacks Investment , Relay Therapeutic , Investment Research , Bank Deutsche Girozentrale , Retirement System , Great West Life Assurance , West Life Assurance , Nasdaq Rlay ,

Zacks: Brokerages Anticipate Relay Therapeutics, Inc. (NASDAQ:RLAY) to Post -$0.63 Earnings Per Share

Wall Street analysts expect that Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) will announce ($0.63) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Relay Therapeutics’ earnings. The highest EPS estimate is ($0.63) and the lowest is ($0.64). Relay Therapeutics reported earnings per share of ($2.10) during the […] ....

New York , United States , Donalda Bergstrom , Dekabank Deutsche Girozentrale , York State Common Retirement Fund , Board Of Administration Florida Retirement System , Principal Financial Group Inc , Berenberg Bank , Zacks Investment Research , Relay Therapeutics Inc , Royal Bank , Wall Street , Relay Therapeutics , Get Rating , Relay Therapeutic , Florida Retirement System , Financial Group , Bank Deutsche Girozentrale , Nasdaq Rlay ,

Vaxart (NASDAQ:VXRT) versus Relay Therapeutics (NASDAQ:RLAY) Critical Contrast

Vaxart (NASDAQ:VXRT – Get Rating) and Relay Therapeutics (NASDAQ:RLAY – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Volatility and Risk Vaxart has a beta of 0.41, indicating that […] ....

United States , United Kingdom , South San Francisco , Allostery Inc , Relay Therapeutics Inc , De Shaw Research , Vaxart Company Profile Get Rating , Relay Therapeutics Company Profile Get Rating , Vaxart Inc , Genentech Inc , Get Rating , Relay Therapeutics , Given Vaxart , Relay Therapeutic , Company Profile , Therapeutics Company Profile , Shaw Research , Nasdaq Vxrt , Stock Comparison , Stock Analysis ,

Relay Therapeutics, Inc. (NASDAQ:RLAY) Expected to Announce Earnings of -$0.63 Per Share

Analysts expect that Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) will post ($0.63) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have provided estimates for Relay Therapeutics’ earnings. The lowest EPS estimate is ($0.64) and the highest is ($0.63). Relay Therapeutics posted earnings of ($0.47) per share in the same quarter […] ....

Sanjiv Patel , Thomas Catinazzo , Berenberg Bank , Zacks Investment Research , Blackrock Inc , Bellevue Group , Jpmorgan Chase Co , Relay Therapeutics Inc , Casdin Capital , Relay Therapeutics Company Profile Get Rating , Relay Therapeutics , Get Rating , Relay Therapeutic , Investment Research , State Street Corp , Street Corp , Therapeutics Company Profile , Nasdaq Rlay ,